They are SLC9A3R1, VCP, NDUFS1, EEF1D, HPCAL1, EZR, SET, HNRNPK with low expression level in primary RCC but high in the bone metastasis lesions of RCC patients (Fig. 5). Here, SET is linked to renal cell carcinoma.